key: cord-0874388-8q8xn87m authors: Sarapultsev, Alexey; Sarapultsev, Petr title: Immunological environment shifts during pregnancy may affect the risk of developing severe complications in COVID‐19 patients date: 2020-06-09 journal: Am J Reprod Immunol DOI: 10.1111/aji.13285 sha: f8ced58d8bc1d1887407700a0e1f19031b124658 doc_id: 874388 cord_uid: 8q8xn87m PROBLEM: The 2019 novel coronavirus disease (COVID‐19) has been rapidly spreading out in China and all over the world. Because of the immune reaction severity, 20.3% of COVID‐19 patients required intensive care unit, and 32.8% presented with acute respiratory distress syndrome (ARDS). In this regard, the urgent question that needs to be addressed promptly includes whether pregnant women with COVID‐19 will develop distinct symptoms from non‐pregnant and what are the reasons for that. RESULTS: According to the literature data, clinical characteristics of pregnant women with COVID‐19 were similar to those of non‐pregnant adults and no significant differences in gestational age, postpartum hemorrhage, and perineal resection rates between pregnant women with and without COVID‐19 were found. There is also a tendency that COVID‐19 disease progresses slowly in pregnant women and does not often result in fatal pregnancy complications. CONCLUSIONS: The predominant Th2‐type immunity and the action of T‐regs can play an important role in preventing the excess systemic inflammatory reaction and the development of life‐threatening complications as ARDS and MODS in COVID‐19 patients. This suggests a search for new drugs aimed at the suppression of effector functions and induction of tolerance, which will reduce the frequency of life‐threatening complications, including ARDS. The first case of coronavirus virus disease 2019 (COVID-19) was revealed in Wuhan in December 2019 1 ; the virus spread in China and then globally 2 . According to the increasing growth rate of coronavirus cases, this outbreak was declared a Public Health Emergency of International Concern on 30 January 2020 by the WHO Emergency Committee 3 . This article is protected by copyright. All rights reserved The most frequent symptoms in mild and moderate cases of COVID-19 were fever, anosmia, or shortness of breath, which appears to be more frequent in adults than children, as well as cough, dyspnea, and myalgia, among other clinical features 4 . The laboratory abnormalities included increased values of C-reactive protein, erythrocyte sedimentation rate, lactate dehydrogenase, and D-dimer 4, 5 . According to the meta-analysis of AJ Rodriguez-Morales et al (2020), lymphopenia was detected in more than 40% of patients 5 . The frequency of lymphopenia found suggests that COVID-19 acted on T lymphocytes, as does SARS-CoV, maybe including depletion of CD4 and CD8 cells 5 . Virus particles spread through the respiratory mucosa, initially using the ACE2 receptor at ciliated bronchial epithelial cells, and then infect other cells, which causes a "cytokine storm" in the body and generates a series of immune responses 6 . The "cytokine storm" with a hyper-innate inflammatory response in the lungs of COVID-19 patients is driven mostly by the IL-6, which is produced by monocytes and macrophages [7] [8] [9] and may serve as a predictive biomarker for disease severity 9 or a target for the therapy development 8, 10 . Because of the immune reaction severity, 20.3% of COVID-19 patients required intensive care unit, 32.8% presented with acute respiratory distress syndrome (ARDS), 6.2% with shock 5 . It has been shown that ARDS occurs even when the viral load decreases 11, 12 , which suggests that the over-reactivity of the immune system and not the action of the virus are responsible for the occurrence of ARDS, and the attenuation of the "cytokine storm" by targeting several key steps in the process could bring about improved outcomes 8, 10, 13 . In this regard, the urgent question that needs to be addressed promptly includes whether pregnant women with COVID-19 will develop distinct symptoms from non-pregnant and what are the reasons for that. This is of particular relevance to the fact that pregnant women infected with other respiratory viruses, e.g. H1N1 influenza, Zika virus, and SARS-CoV were reported with more fetal adverse events 14 . The first part of the question has already been discussed in several studies [15] [16] [17] [18] [19] This article is protected by copyright. All rights reserved significant differences in gestational age, postpartum hemorrhage, and perineal resection rates between pregnant women with the clinical diagnosis of COVID-19 and pregnant women without COVID-19 were found 16 . Likewise, there were no significant differences in birth weight of neonates and neonatal asphyxia rates between the two groups 16 . Likewise, the SARS-CoV-2 infection during pregnancy was not associated with an increased risk of spontaneous abortion and spontaneous preterm birth 17 A healthy human pregnancy requires the sustentation of active immunotolerance toward the semiallogeneic fetus 33 , involving the suppression of effector functions and induction of tolerance, originally described as a Th2 skewing and now explained as a balance between Th1, Th2, Th17, Treg and regulatory responses [33] [34] [35] [36] [37] [38] . The protective benefits of the observed Th2 cell's rise in pregnancy 34 can be mediated by the up-regulation of Th2 response with the increase of IL-4 and IL-10, or down-regulation of a Th1 response 35 , or even via CD4+CD25+Treg cells [36] [37] [38] . This article is protected by copyright. All rights reserved the viral clearance in influenza patients 14 . According to the analysis, conducted by SQ Du and W Yuan (2020) delaying the onset or suppressing the adaptive immune response, or avoiding its interference with the innate immune response might represent the potential treatment strategies for high-risk COVID-19 patients 39 . Thus, the foregoing not only explains the absence of severe outcomes in pregnant women with COVID-19 but also suggests a search for new drugs aimed at partial immunomodulation involving the suppression of effector functions and induction of tolerance, which will reduce the frequency of life-threatening complications, including ARDS 13 . The existence of the temporary changes in the immune response during pregnancy represents themselves in the Th1 inflammation-like condition early in pregnancy, with the shift to a state of temporal Th2-skewed immune-tolerance during the second trimester and a second shift during parturition 40, 41 can be the limiting factor for the proposed hypothesis, and therefore, the effect of COVID-19 in pregnancy warrants further studies. With that, the idea that pregnant women are more susceptible to respiratory pathogens and thus may be more susceptible to SARS-CoV-2 than the general population 42 has not been confirmed yet, while the limited amount of data received so far, allows only hypothesis building and suggesting ideas for further research. A Novel Coronavirus from Patients with Pneumonia in China COVID-19 and digital epidemiology The COVID-19 epidemic A major outbreak of severe acute respiratory syndrome in Hong Kong Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis Accepted Article This article is protected by copyright. All rights reserved Going global -Travel and the 2019 novel coronavirus Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure SARS-CoV-2 and COVID-19: is interleukin-6 (IL-6) the "culprit lesion Prevention and treatment of COVID-19 disease by controlled modulation of innate immunity Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)? Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice Exacerbated innate host response to SARS-CoV in aged non-human primates COVID-19: Melatonin as a potential adjuvant treatment Coronavirus Disease 2019 (COVID-19) and Pregnancy: Responding to a Rapidly Evolving Situation Coronavirus disease 2019 (COVID-19) and pregnancy: a systematic review Analysis of vaginal delivery outcomes among pregnant women in Wuhan, China during the COVID-19 pandemic Coronavirus disease 2019 (COVID-19) in pregnant women: A report based on 116 cases Coronavirus disease 2019 in pregnancy A mechanistic analysis placental intravascular thrombus formation in COVID-19 patients The SARS-CoV-2 receptor ACE2 expression of maternal-fetal interface and fetal organs by single-cell transcriptome study SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor Uteroplacental expression of angiotensin-(1-7) and ACE2 in the pregnant guinea-pig The expression and localization of the human placental prorenin/renin-angiotensin system throughout pregnancy: roles in trophoblast invasion and angiogenesis? Placenta The uterine placental bed Renin-Angiotensin system in normal and preeclamptic pregnancy Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2: A Systematic Review Vertical Transmission of Coronavirus Disease 19 (COVID-19) from Infected Pregnant Mothers to Neonates: A Review Detection of SARS-COV-2 in Placental and Fetal Membrane Samples Vertical transmission of COVID-19: SARS-CoV-2 RNA on the fetal side of the placenta in pregnancies with COVID-19 positive mothers and neonates at birth Placental Pathology in Covid-19 Positive Mothers: Preliminary Findings Analysis of complement deposition and viral RNA in placentas of COVID-19 patients Adaptive Immune Responses During Pregnancy Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy Differential actions of glycodelin-A on Th-1 and Th-2 cells: a paracrine mechanism that could produce the Th-2 dominant environment during pregnancy The remission of rheumatoid arthritis during pregnancy Fetal alloantigen is responsible for the expansion of the CD4(+)CD25(+) regulatory T cell pool during pregnancy Phenotypic characterization of regulatory T cells in the human decidua Immune Suppression in Pregnancy and Cancer: Parallels and Insights Mathematical Modeling of Interaction between Innate and Adaptive Immune Responses in COVID-19 and Implications for Viral Pathogenesis The inflammation paradox in the evolution of mammalian pregnancy: turning a foe into a friend This article is protected by copyright. All rights reserved